Could the Next Blockbuster Drug Be Lab-Rat Free? – The New York Times
… of research policy at the Physicians Committee for Responsible Medicine, a nonprofit group that advocates for alternatives to animal testing.
» Read more… of research policy at the Physicians Committee for Responsible Medicine, a nonprofit group that advocates for alternatives to animal testing.
» Read moreTransformational results in Phase 3 ENHANCE program for COPD · NDA submission expected Q2 2023 · Strong balance sheet to support planned US commercial …
» Read morePeople with Type 2 diabetes and heart disease face a high risk of serious cardiac events, and preventive medications are effective at reducing …
» Read morePhysical exercise is the performance of some activity to either develop or maintain physical fitness and overall health and is important as a means of …
» Read moreThe GLP-1 medicines are already used to treat diabetes, and they generate $23 billion in annual sales. But using the same drugs to also treat obesity …
» Read moreAstraZeneca said on Monday a mid-stage trial of its cancer drug Enhertu showed positive results across multiple HER2-expressing advanced solid …
» Read moreAlternative medicine companies in India offer a range of products and services, including herbal remedies, Ayurvedic treatments, homeopathy, and …
» Read moreThe scheme has also been made available to patients with conditions like asthma and chronic obstructive pulmonary disease (COPD).
» Read moreA new study has found that scientists could soon be able to predict an imminent presence of cardiovascular disease in patients.
» Read more… is just as important that we address their need for physical activity. … exercising your body and learning how to physically and emotionally …
» Read moreDear Abby: My best friend, who is 54, has had Type 1 diabetes since she was 9. She takes two insulin shots a day — one in the morning and one in …
» Read moreSINGAPORE – Subsidised cancer patients will receive higher insurance coverage for cancer treatment services from April 1 following a review.
» Read more